In vivo imaging of tau pathology using multi-parametric quantitative MRI
暂无分享,去创建一个
Sébastien Ourselin | Emily C. Collins | Marc Modat | Jack A. Wells | Mark F. Lythgoe | Manuel Jorge Cardoso | Xavier Golay | Niall Colgan | Adam J. Schwarz | Holly E. Holmes | James M. O'Callaghan | Bernard Siow | Nick M. Powell | Ozama Ismail | Ross A. Johnson | Tracey K. Murray | Michael J. O'Neill | S. Richardson | F. Torrealdea | S. Walker-Samuel | M. Rega | Zeshan Ahmed | M. Lythgoe | M. Modat | S. Ourselin | X. Golay | A. Schwarz | M. Cardoso | S. Walker-Samuel | N. Colgan | M. O'Neill | S. Richardson | B. Siow | J. Wells | Z. Ahmed | T. Murray | F. Torrealdea | M. Rega | O. Ismail | N. Powell | E. Collins | T. Murray
[1] Thomas E. Nichols,et al. Thresholding of Statistical Maps in Functional Neuroimaging Using the False Discovery Rate , 2002, NeuroImage.
[2] J. Chin,et al. Selecting a mouse model of Alzheimer's disease. , 2010, Methods in molecular biology.
[3] D. Royall,et al. Alzheimer disease as a vascular disorder: nosological evidence. , 2002, Stroke.
[4] C. Jack,et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease , 1997, Neurology.
[5] Seong-Gi Kim. Quantification of relative cerebral blood flow change by flow‐sensitive alternating inversion recovery (FAIR) technique: Application to functional mapping , 1995, Magnetic resonance in medicine.
[6] C. Jack,et al. Mild cognitive impairment and Alzheimer disease: regional diffusivity of water. , 2001, Radiology.
[7] M. Lythgoe,et al. The importance of RF bandwidth for effective tagging in pulsed arterial spin labeling MRI at 9.4T , 2012, NMR in biomedicine.
[8] R. Turner,et al. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[9] Nick C Fox,et al. The clinical use of structural MRI in Alzheimer disease , 2010, Nature Reviews Neurology.
[10] Shu-Wei Sun,et al. Detection of age-dependent brain injury in a mouse model of brain amyloidosis associated with Alzheimer's disease using magnetic resonance diffusion tensor imaging , 2005, Experimental Neurology.
[11] B. Hyman,et al. Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function , 2005, Science.
[12] W. Bowers,et al. Triple‐transgenic Alzheimer's disease mice exhibit region‐specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology , 2009, Glia.
[13] Anatol C. Kreitzer,et al. Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease , 2007, Neuron.
[14] Yu-Ling Chang,et al. Altered brain response for semantic knowledge in Alzheimer's disease , 2011, Neuropsychologia.
[15] E. Roberson,et al. Mouse models of Alzheimer's disease , 2012, Brain Research Bulletin.
[16] F. Metzger,et al. Cortical hypoperfusion in the B6.PS2APP mouse model for Alzheimer's disease: Comprehensive phenotyping of vascular and tissular parameters by MRI , 2009, Magnetic resonance in medicine.
[17] Jayaram K. Udupa,et al. New variants of a method of MRI scale standardization , 2000, IEEE Transactions on Medical Imaging.
[18] C. Żekanowski,et al. Mitochondrial dysfunction and Alzheimer's disease , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[19] Matthias J. Müller,et al. Ultrastructural Hippocampal and White Matter Alterations in Mild Cognitive Impairment: A Diffusion Tensor Imaging Study , 2004, Dementia and Geriatric Cognitive Disorders.
[20] Naruhiko Sahara,et al. Propagation of Tau Pathology in a Model of Early Alzheimer's Disease , 2012, Neuron.
[21] C. Packer,et al. Diagnosing Alzheimer’s disease: are we any nearer to useful biomarker-based, non-invasive tests? , 2013, GMS health technology assessment.
[22] Xavier Golay,et al. Imaging Brain Deoxyglucose Uptake and Metabolism by Glucocest MRI , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[23] Marie Kelly-Worden,et al. Mitochondrial Dysfunction and Alzheimer’s Disease , 2013 .
[24] Xiaolei Song,et al. Nuts and bolts of chemical exchange saturation transfer MRI , 2013, NMR in biomedicine.
[25] K. Ashe,et al. Age-Dependent Neurofibrillary Tangle Formation, Neuron Loss, and Memory Impairment in a Mouse Model of Human Tauopathy (P301L) , 2005, The Journal of Neuroscience.
[26] Clifford R Jack,et al. Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play. , 2012, Radiology.
[27] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[28] Nirbhay N. Yadav,et al. Chemical exchange saturation transfer (CEST): What is in a name and what isn't? , 2011, Magnetic resonance in medicine.
[29] Efstathios D. Gennatas,et al. Predicting Regional Neurodegeneration from the Healthy Brain Functional Connectome , 2012, Neuron.
[30] Diane Stephenson,et al. Volumetric MRI and MRS provide sensitive measures of Alzheimer's disease neuropathology in inducible Tau transgenic mice (rTg4510) , 2011, NeuroImage.
[31] C. Jack,et al. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia , 2002, Neurology.
[32] Yoshinori Kato,et al. Natural D‐glucose as a biodegradable MRI contrast agent for detecting cancer , 2012, Magnetic resonance in medicine.
[33] Sébastien Ourselin,et al. Fast free-form deformation using graphics processing units , 2010, Comput. Methods Programs Biomed..
[34] Lei Wang,et al. Correlations Between Antemortem Hippocampal Volume and Postmortem Neuropathology in AD Subjects , 2004, Alzheimer disease and associated disorders.
[35] S. Rose,et al. Gray and white matter changes in Alzheimer's disease: A diffusion tensor imaging study , 2008, Journal of magnetic resonance imaging : JMRI.
[36] F. Hentschel,et al. Leistet die Magnetization-Transfer-Ratio (MTR) einen Beitrag zur Diagnostik und Differenzialdiagnostik der Demenzen? , 2004 .
[37] D. Le Bihan,et al. Diffusion tensor imaging: Concepts and applications , 2001, Journal of magnetic resonance imaging : JMRI.
[38] John A Detre,et al. Arterial spin labeling MRI: an emerging biomarker for Alzheimer's disease and other neurodegenerative conditions. , 2012, Current opinion in neurology.
[39] M. Damian,et al. [Does magnetization transfer ratio (MTR) contribute to the diagnosis and differential diagnosis of the dementias?]. , 2004, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.
[40] Sébastien Ourselin,et al. STEPS: Similarity and Truth Estimation for Propagated Segmentations and its application to hippocampal segmentation and brain parcelation , 2013, Medical Image Anal..
[41] Jefferson W. Kinney,et al. Alzheimer's disease biomarkers: Correspondence between human studies and animal models , 2013, Neurobiology of Disease.
[42] A. Connelly,et al. Anisotropic noise propagation in diffusion tensor MRI sampling schemes , 2003, Magnetic resonance in medicine.
[43] F. Admiraal-Behloul,et al. Magnetization transfer imaging of gray and white matter in mild cognitive impairment and Alzheimer's disease , 2006, Neurobiology of Aging.
[44] C Caltagirone,et al. When, where, and how the corpus callosum changes in MCI and AD , 2010, Neurology.
[45] John Russell,et al. Dysmyelination Revealed through MRI as Increased Radial (but Unchanged Axial) Diffusion of Water , 2002, NeuroImage.
[46] Richard J. Caselli,et al. Ushering in the study and treatment of preclinical Alzheimer disease , 2013, Nature Reviews Neurology.
[47] C. Rampon,et al. Impaired neurogenesis, neuronal loss, and brain functional deficits in the APPxPS1-Ki mouse model of Alzheimer's disease , 2011, Neurobiology of Aging.
[48] P. Scheltens,et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria , 2007, The Lancet Neurology.
[49] Alan C. Evans,et al. A nonparametric method for automatic correction of intensity nonuniformity in MRI data , 1998, IEEE Transactions on Medical Imaging.
[50] C. Rae,et al. Glutamate Metabolism is Impaired in Transgenic Mice with Tau Hyperphosphorylation , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[51] Sheng-Kwei Song,et al. Diffusion tensor imaging detects age-dependent white matter changes in a transgenic mouse model with amyloid deposition , 2004, Neurobiology of Disease.
[52] J. Trojanowski,et al. Neurodegenerative tauopathies. , 2001, Annual review of neuroscience.
[53] L. Mucke,et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.
[54] Clifford R. Jack,et al. Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage , 2008, NeuroImage.
[55] M. Weiner,et al. A Network Diffusion Model of Disease Progression in Dementia , 2012, Neuron.
[56] C. Jack,et al. MRI correlates of neurofibrillary tangle pathology at autopsy , 2008, Neurology.
[57] Martin Beibel,et al. Transmission and spreading of tauopathy in transgenic mouse brain , 2009, Nature Cell Biology.
[58] J B Langbaum. Correction: Ushering in the study and treatment of preclinical Alzheimer disease , 2013 .
[59] S Warach,et al. A general kinetic model for quantitative perfusion imaging with arterial spin labeling , 1998, Magnetic resonance in medicine.
[60] C. Plata-salamán,et al. Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.
[61] P. T. Nguyen,et al. Dendritic Spine Abnormalities in Amyloid Precursor Protein Transgenic Mice Demonstrated by Gene Transfer and Intravital Multiphoton Microscopy , 2005, The Journal of Neuroscience.
[62] Naruhiko Sahara,et al. Age-related decline in white matter integrity in a mouse model of tauopathy: an in vivo diffusion tensor magnetic resonance imaging study , 2014, Neurobiology of Aging.
[63] Mark F. Lythgoe,et al. In vivo imaging of glucose uptake and metabolism in tumors , 2012, Nature Medicine.
[64] A. Dale,et al. Regional rates of neocortical atrophy from normal aging to early Alzheimer disease , 2009, Neurology.